Different mechanisms underlie the effects of acute and long-term inhibition of nitric oxide synthases in antigen-induced pulmonary eosinophil recruitment in BALB/C mice

Pulmonary Pharmacology and Therapeutics

Volumn 22, Issue 1, 2009, Pages 1-8

  Lintomen, Leticia ^a   Souza Filho, Luis Gustavo ^a   Ferreira, Tatiane ^a   Camargo, Enilton A ^a   Teixeira, Simone A ^b   Muscará, Marcelo N ^b   Landgraf, Richardt G ^b   Jancar, Sonia ^b   Mendes, Gustavo D ^a   De Nucci, Gilberto ^a   Antunes, Edson ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bioavailability; Eosinophil; Eotaxin; IgE; l NAME; Nitric oxide synthase

Indexed keywords

AMINOGUANIDINE; ANTIGEN; ARGININE; DRINKING WATER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; OVALBUMIN;

AMINO ACID BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; BAGG ALBINO MOUSE; BIOCHEMISTRY; BRAIN; CELL COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; EOSINOPHIL; LONG TERM CARE; LUNG; LUNG ALVEOLUS CELL; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; THERAPY EFFECT;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; BRAIN; BRONCHOALVEOLAR LAVAGE FLUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; EOSINOPHILS; LUNG; MALE; MICE; MICE, INBRED BALB C; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OVALBUMIN;

EID: 58349094157     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2008.10.003     Document Type: Article

References (45)

1. Rothenberg M.E., and Hogan S.P. The eosinophil. Annu Rev Immunol 24 (2006) 147-174
2. Spina D., and Page C.P. Asthma - a need for a rethink?. Trends Pharmacol Sci 23 (2002) 311-315
3. Kroegel C., Virchow Jr. J.C., Luttmann W., Walker C., and Warner J.A. Pulmonary immune cells in health and disease: the eosinophil leukocyte (part I). Eur Respir J 7 (1994) 519-543
4. Collins P.D., Marleau S., Griffiths-Johnson D.A., Jose P.J., and Williams T.J. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 182 (1995) 1169-1174
5. Rankin S.M., Conroy D.M., and Williams T.J. Eotaxin and eosinophil recruitment: implications for human disease. Mol Med Today 6 (2000) 20-27
6. Folkerts G., and Nijkamp F.P. Nitric oxide in asthma therapy. Curr Pharm Des 12 (2006) 3221-3232
7. Zanardo R.C., Costa E., Ferreira H.H., Antunes E., Martins A.R., Murad F., et al. Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils. Proc Natl Acad Sci U S A 94 (1997) 14111-14114
8. Feder L.S., Stelts D., Chapman R.W., Manfra D., Crawley Y., Jones H., et al. Role of nitric oxide on eosinophilic lung inflammation in allergic mice. Am J Respir Cell Mol Biol 17 (1997) 436-442
9. Iijima H., Uchida Y., Endo T., Xiang A., Shirato M., Nomura A., et al. Role of endogenous nitric oxide in allergen-induced airway responses in guinea-pigs. Br J Pharmacol 124 (1998) 1019-1028
10. Xiong Y., Karupiah G., Hogan S.P., Foster P.S., and Ramsay A.J. Inhibition of allergic inflammation in mice lacking nitric oxide synthase 2. J Immunol 62 (1999) 445-452
11. Trifilieff A., Fujitani Y., Mentz F., Dugas B., Fuentes M., and Bertrand C. Inducible nitric oxide synthase inhibitors suppress airway inflammation in mice through down-regulation of chemokine expression. J Immunol 165 (2000) 1526-1533
12. Muijsers R.B., van Ark I., Folkerts G., Koster A.S., van Oosterhout A.J., Postma D.S., et al. Apocynin and 1400 W prevents airway hyperresponsiveness during allergic reactions in mice. Br J Pharmacol 134 (2001) 434-440
13. Koarai A., Ichinose M., Sugiura H., Tomaki M., Watanabe M., Yamagata S., et al. iNOS depletion completely diminishes reactive nitrogen-species formation after an allergic response. Eur Respir J 20 (2002) 609-616
14. Eynott P.R., Groneberg D.A., Caramori G., Adcock I.M., Donnelly L.E., Kharitonov S., et al. Role of nitric oxide in allergic inflammation and bronchial hyperresponsiveness. Eur J Pharmacol 452 (2002) 123-133
15. Birrell M.A., McCluskie K., Haddad el.-B., Battran C.H., Webber S.E., Foster M.L., et al. Pharmacological assessment of the nitric-oxide synthase isoform involved in eosinophilic inflammation in a rat model of sephadex-induced airway inflammation. J Pharmacol Exp Ther 304 (2003) 1285-1291
16. Landgraf R.G., Russo M., and Jancar S. Acute inhibition of inducible nitric oxide synthase but not its absence suppresses asthma-like responses. Eur J Pharmacol 518 (2005) 212-220
17. Thomazzi S., Ferreira H.H.A., Conran N., De Nucci G., and Antunes E. Role of nitric oxide on in vitro human eosinophil migration. Biochem Pharmacol 62 (2001) 1417-1421
18. Thomazzi S.M., Moreira J., Marcondes S., De Nucci G., and Antunes E. Role of cyclic GMP on inhibition by nitric oxide donors of human eosinophil chemotaxis in vitro. Br J Pharmacol 141 (2004) 653-660
19. Zatz R., and Baylis C. Chronic nitric oxide inhibition model six years on. Hypertension 32 (1998) 958-964
20. Ferreira H.H., Medeiros M.V., Lima C.S., Flores C.A., Sannomiya P., Autunes E., et al. Inhibition of eosinophil chemotaxis by chronic blockade of nitric oxide biosynthesis. Eur J Pharmacol 310 (1996) 201-207
21. Ferreira H.H., Bevilacqua E., Gagioti S.M., De Luca I.M., Zanardo R.C., Teixeira C.E., et al. Nitric oxide modulates eosinophil infiltration in antigen-induced airway inflammation in rats. Eur J Pharmacol 358 (1998) 253-259
22. Ferreira H.H., Costa R.A., Jacheta J.M., Martins A.R., Medeiros M.V., Macedo-Soares M.F., et al. Modulation of eosinophil migration from bone marrow to lungs of allergic rats by nitric oxide. Biochem Pharmacol 68 (2004) 631-639
23. Ribeiro M.O., Antunes E., de Nucci G., Lovisolo S.M., and Zatz R. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20 (1992) 298-303
24. Moreno Jr. H., Metze K., Bento A.C., Antunes E., Zatz R., and de Nucci G. Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease. Basic Res Cardiol 91 (1996) 248-255
25. Takano H., Lim H.-B., Miyabara Y., Ichinose T., Yoshikawa T., and Sagai M. Manipulation of the l-arginine-nitric oxide pathway in airway inflammation induced by diesel exhaust particles in mice. Toxicology 139 (1999) 19-26
26. Henningsson R., Alm P., Lindstrom E., and Lundquist I. Chronic blockade of NO synthase paradoxically increases islet NO production and modulates islet hormone release. Am J Physiol Endocrinol Metab 279 (2000) 95-107
27. Faria M.S., Muscará M.N., Moreno Júnior H., Teixeira S.A., Dias H.B., De Oliveira B., et al. Acute inhibition of nitric oxide synthesis induces anxiolysis in the plus maze test. Eur J Pharmacol 323 (1997) 37-43
28. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
29. Mathrani V.C., Kenyon N.J., Zeki A., and Last J.A. Mouse models of asthma: can they give us mechanistic insights into the role of nitric oxide?. Curr Med Chem 14 (2007) 2204-2213
30. Iijima H., Duguet A., Eum S.Y., Hamid Q., and Eidelman D.H. Nitric oxide and protein nitration are eosinophil dependent in allergen-challenged mice. Am J Respir Crit Care Med 163 (2001) 1233-1240
31. Prado C.M., Leick-Maldonado E.A., Kasahara D.I., Capelozzi V.L., Martins M.A., and Tibério I.F. Effects of acute and chronic nitric oxide inhibition in an experimental model of chronic pulmonary allergic inflammation in guinea pigs. Am J Physiol Lung Cell Mol Physiol 289 (2005) L677-L683
32. Denburg J.A., Sehmi R., Saito H., Pil-Seob J., Inman M.D., and O'Byrne P.M. Systemic aspects of allergic disease: bone marrow responses. J Allergy Clin Immunol 106 (2000) S242-S246
33. Wood L.J., Inman M.D., Denburg J.A., and O'Byrne P.M. Allergen challenge increases cell traffic between bone marrow and lung. Am J Respir Cell Mol Biol 18 (1998) 759-767
34. Chin J.E., Winterrowd G.E., Hatfield C.A., Brashler J.R., Griffin R.L., Vonderfecht S.L., et al. Involvement of intercellular adhesion molecule-1 in the antigen-induced infiltration of eosinophils and lymphocytes into the airways in a murine model of pulmonary inflammation. Am J Respir Cell Mol Biol 18 (1998) 158-167
35. Kung T.T., Jones H., Adams III G.K., Umland S.P., Kreutner W., Egan R.W., et al. Characterization of a murine model of allergic pulmonary inflammation. Int Arch Allergy Immunol 105 (1994) 83-90
36. Shahabuddin S., Ponath P., and Schleimer R.P. Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines. J Immunol 164 (2000) 3847-3854
37. Teran L.M. CCL chemokines and asthma. Immunol Today 21 (2000) 235-241
38. Kaplan A.P. Chemokines, chemokines receptors and allergy. Int Arch Allergy Immunol 124 (2001) 423-431
39. Tachimoto H., Ebisawa M., and Bochner B.S. Cross-talk between integrins and chemokines that influences eosinophil adhesion and migration. Int Arch Allergy Immunol 1281 (2002) 18-20
40. Jahnz-Rózyk K., Plusa T., and Mierzejewska J. Eotaxin in serum of patients with asthma or chronic obstructive pulmonary disease: relationship with eosinophil cationic protein and lung function. Mediators Inflamm 9 (2000) 175-179
41. Tateno H., Nakamura H., Minematsu N., Nakajima T., Takahashi S., Nakamura M., et al. Plasma eotaxin level and severity of asthma treated with corticosteroid. Respir Med 98 (2004) 782-790
42. Yamamoto K., Takanashi S., Hasegawa Y., Kanehira Y., Kaizuka M., and Okumura K. Eotaxin level in induced sputum is increased in patients with bronchial asthma and in smokers. Respiration 70 (2003) 600-605
43. Li J., Saito H., Crawford L., Inman M.D., Cyr M.M., and Denburg J.A. Haemopoietic mechanisms in murine allergic upper and lower airway inflammation. Immunology 114 (2005) 386-396
44. Pfeiffer S., Leopold E., Schmidt K., Brunner F., and Mayer B. Inhibition of nitric oxide synthesis by NG-nitro-l-arginine methyl ester (l-NAME): requirement for bioactivation to the free acid NG-nitro-l-arginine. Br J Pharmacol 118 (1996) 1433-1440
45. Angeli P., Prado C.M., Xisto D.G., Silva P.L., Pássaro C.P., Nakazato H.D., et al. Effects of chronic l-NAME treatment lung tissue mechanics, eosinophilic and extracellular matrix responses induced by chronic pulmonary inflammation. Am J Physiol Lung Cell Mol Physiol 294 (2008) L1197-L1205